These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35137367)

  • 61. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Paradigm Gap in Host-Pathogen Interaction Studies: Lesson from the COVID-19 Pandemic.
    Pooranachithra M; Muthubharathi BC; Balamurugan K
    Adv Exp Med Biol; 2021; 1353():47-70. PubMed ID: 35137367
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PHILM2Web: A high-throughput database of macromolecular host-pathogen interactions on the Web.
    Le TD; Nguyen PD; Korkin D; Thieu T
    Database (Oxford); 2022 Jun; 2022():. PubMed ID: 35776535
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new framework for host-pathogen interaction research.
    Yu H; Li L; Huffman A; Beverley J; Hur J; Merrell E; Huang HH; Wang Y; Liu Y; Ong E; Cheng L; Zeng T; Zhang J; Li P; Liu Z; Wang Z; Zhang X; Ye X; Handelman SK; Sexton J; Eaton K; Higgins G; Omenn GS; Athey B; Smith B; Chen L; He Y
    Front Immunol; 2022; 13():1066733. PubMed ID: 36591248
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative Host-Pathogen Interaction Analyses of SARS-CoV2 and Aspergillus fumigatus, and Pathogenesis of COVID-19-Associated Aspergillosis.
    Khan AA; Farooq F; Jain SK; Golinska P; Rai M
    Microb Ecol; 2022 Nov; 84(4):1236-1244. PubMed ID: 34738157
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE).
    Abootalebi S; Aertker BM; Andalibi MS; Asdaghi N; Aykac O; Azarpazhooh MR; Bahit MC; Barlinn K; Basri H; Shahripour RB; Bersano A; Biller J; Borhani-Haghighi A; Brown RD; Campbell BC; Cruz-Flores S; De Silva DA; Di Napoli M; Divani AA; Edgell RC; Fifi JT; Ghoreishi A; Hirano T; Hong KS; Hsu CY; Huang JF; Inoue M; Jagolino AL; Kapral M; Kee HF; Keser Z; Khatri R; Koga M; Krupinski J; Liebeskind DS; Liu L; Ma H; Maud A; McCullough LD; Meyer DM; Mifsud V; Morovatdar N; Nilanont Y; Oxley TJ; Özdemir AÖ; Pandian J; Pantoni L; Papamitsakis NIH; Parry-Jones A; Phan T; Rodriguez G; Romano JG; Sabaa-Ayoun Z; Saber H; Sasannezhad P; Saver JL; Scharf E; Shuaib A; Silver B; Singhal S; Smith CJ; Stranges S; Sylaja PN; Torbey M; Toyoda K; Tsivgoulis G; Wasay M; Yassi N; Yoshimoto T; Zamani B; Zand R
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104938. PubMed ID: 32807412
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies.
    Sardar R; Satish D; Birla S; Gupta D
    Heliyon; 2020 Sep; 6(9):e04658. PubMed ID: 32844125
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.
    Tang Y; Liu J; Zhang D; Xu Z; Ji J; Wen C
    Front Immunol; 2020; 11():1708. PubMed ID: 32754163
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Liver diseases in COVID-19: Etiology, treatment and prognosis.
    Wu J; Song S; Cao HC; Li LJ
    World J Gastroenterol; 2020 May; 26(19):2286-2293. PubMed ID: 32476793
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.
    Alqahtani JS; Oyelade T; Aldhahir AM; Alghamdi SM; Almehmadi M; Alqahtani AS; Quaderi S; Mandal S; Hurst JR
    PLoS One; 2020; 15(5):e0233147. PubMed ID: 32392262
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regulatory networks important for survival of Acinetobacter baumannii within the host.
    Allen JL; Tomlinson BR; Casella LG; Shaw LN
    Curr Opin Microbiol; 2020 Jun; 55():74-80. PubMed ID: 32388085
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Meo SA; Klonoff DC; Akram J
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4539-4547. PubMed ID: 32373993
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comorbidities impact on the prognosis of severe acute community-acquired pneumonia.
    Vidal A; Santos L
    Porto Biomed J; 2017; 2(6):265-272. PubMed ID: 32289091
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Understanding pathways to death in patients with COVID-19.
    Vincent JL; Taccone FS
    Lancet Respir Med; 2020 May; 8(5):430-432. PubMed ID: 32272081
    [No Abstract]   [Full Text] [Related]  

  • 76. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study.
    Du Y; Tu L; Zhu P; Mu M; Wang R; Yang P; Wang X; Hu C; Ping R; Hu P; Li T; Cao F; Chang C; Hu Q; Jin Y; Xu G
    Am J Respir Crit Care Med; 2020 Jun; 201(11):1372-1379. PubMed ID: 32242738
    [No Abstract]   [Full Text] [Related]  

  • 77. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
    Muniyappa R; Gubbi S
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E736-E741. PubMed ID: 32228322
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antihypertensive drugs and risk of COVID-19?
    Tignanelli CJ; Ingraham NE; Sparks MA; Reilkoff R; Bezdicek T; Benson B; Schacker T; Chipman JG; Puskarich MA
    Lancet Respir Med; 2020 May; 8(5):e30-e31. PubMed ID: 32222166
    [No Abstract]   [Full Text] [Related]  

  • 79. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.
    Yang J; Zheng Y; Gou X; Pu K; Chen Z; Guo Q; Ji R; Wang H; Wang Y; Zhou Y
    Int J Infect Dis; 2020 May; 94():91-95. PubMed ID: 32173574
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comorbidities and multi-organ injuries in the treatment of COVID-19.
    Wang T; Du Z; Zhu F; Cao Z; An Y; Gao Y; Jiang B
    Lancet; 2020 Mar; 395(10228):e52. PubMed ID: 32171074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.